These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29386428)

  • 1. [Role of Pharmacy in the Promotion of Drug Safety in Pharmacotherapy].
    Satoh M
    Yakugaku Zasshi; 2018; 138(2):149-150. PubMed ID: 29386428
    [No Abstract]   [Full Text] [Related]  

  • 2. The lay user perspective on the quality of pharmaceuticals, drug therapy and pharmacy services--results of focus group discussions.
    Traulsen JM; Almarsdóttir AB; Björnsdóttir I
    Pharm World Sci; 2002 Oct; 24(5):196-200. PubMed ID: 12426964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks.
    Hung A; Sieluk J; Doshi P
    JAMA Intern Med; 2016 Jan; 176(1):11-2. PubMed ID: 26618769
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of advanced pharmaceutical services on the incidence of adverse drug reactions.
    McKenney JM; Wasserman AJ
    Am J Hosp Pharm; 1979 Dec; 36(12):1691-7. PubMed ID: 525645
    [No Abstract]   [Full Text] [Related]  

  • 5. [How to initiate, optimise and stop pharmacological treatments: applications in real life].
    Scheen AJ
    Rev Med Liege; 2015 Jan; 70(1):49-53. PubMed ID: 25902607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUROmediCAT: Safety of Medication Use in Pregnancy.
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24 Suppl 2():1-2. PubMed ID: 26395592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems presented by the introduction of a new drug].
    van Cauwenberge H; Luyckx A
    Rev Med Liege; 1970 Dec; 25(24):810-5. PubMed ID: 5502750
    [No Abstract]   [Full Text] [Related]  

  • 8. Preface.
    Dodd S
    Curr Drug Saf; 2019; 14(1):2. PubMed ID: 30698108
    [No Abstract]   [Full Text] [Related]  

  • 9. Fake medicines are everybody's business.
    Benton D; Williamson L
    Aust Nurs Midwifery J; 2014 May; 21(10):26. PubMed ID: 24941562
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a Community Pharmacy-Based Screening Questionnaire to Identify Patients at Risk for Drug Therapy Problems.
    Pammett RT; Blackburn D; Taylor J; Mansell K; Kwan D; Papoushek C; Jorgenson D
    Pharmacotherapy; 2015 Sep; 35(9):881-6. PubMed ID: 26406776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [STABILITY OF DRUGS. II. SIMULTANEOUS REACTIONS].
    PHOHORSKY J; VACHEK J; KONECNY J
    Cesk Farm; 1963 Dec; 12():532-6. PubMed ID: 14118732
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best practices for managing quality and safety of foreign particles in orally inhaled and nasal drug products, and an evaluation of clinical relevance.
    Blanchard J; Coleman J; Crim C; Dabreu-Hayling C; Fries L; Ghaderi R; Haeberlin B; Malcolmson R; Mittelman S; Nagao L; Saracovan I; Shtohryn L; Snodgrass-Pilla C; Sundahl M; Wolff R
    Pharm Res; 2007 Mar; 24(3):471-9. PubMed ID: 17252189
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced diseases focus of pharmacy manual.
    Sipkoff M
    Manag Care; 2010 Apr; 19(4):11-2. PubMed ID: 20446556
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reactions.
    Wooten J
    South Med J; 2006 Sep; 99(9):915. PubMed ID: 17004521
    [No Abstract]   [Full Text] [Related]  

  • 16. EUROmediCAT Recommendations for European Pharmacovigilance concerning safety of medication use in pregnancy.
    EUROmediCAT Steering Group
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24 Suppl 2():3-7. PubMed ID: 26395593
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacovigilance in pharmacy practice].
    Duquet N
    J Pharm Belg; 2011 Dec; (4):97-103. PubMed ID: 22299235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerances for extemporaneously compounded pharmaceuticals; statistical development.
    GOLDSTEIN SW
    Pharm J; 1948 Oct; 107(4432):250. PubMed ID: 18889420
    [No Abstract]   [Full Text] [Related]  

  • 19. Advocating a person-centered care approach to drug safety.
    Scerri J; Churchill J; Banks D; Sultana J
    Expert Opin Drug Saf; 2021 Mar; 20(3):255-258. PubMed ID: 33401935
    [No Abstract]   [Full Text] [Related]  

  • 20. [Not Available].
    Krähenbühl S
    Ther Umsch; 2016 Nov; 73(11):701-706. PubMed ID: 28276266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.